Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial

Basnyat, Buddha; H. Gertsch, Jeffrey; W. Johnson, Eric; Castro-Marin, Franco; Inoue, Yoshio; Yeh, Clement

doi:10.1089/152702903321488979

Public

Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial

Published in High Altitude Medicine & Biology • Mar 1, 2003

Authors:

Buddha Basnyat

Jeffrey H. Gertsch

Eric W. Johnson

Abstract

The objective of this study was to determine the efficacy of low-dose acetazolamide (125 mg twice daily) for the prevention of acute mountain sickness (AMS). The design was a prospective, double-blind, randomized, placebo-controlled trial in the Mt. Everest region of Nepal between Pheriche (4243 m),...

Subject

Acetazolamide

Medicine

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!